Chemistry, Pharmacokinetics, Pharmacodynamics and Analytical Methods of Bilastine, a Histamine H1 Receptor Antagonist : An Update

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

Bilastine (BIL) is the new generation antihistamine that is used to relieve the symptoms of hayfever, chronic urticaria and other forms of allergic rhinitis. Chemically it is known 2-[4-[2-[4-[1- (2-ethoxyethyl) benzimidazole-2-yl] piperidine-1-yl] ethyl] phenyl]-2-methylpropane acid. The chemical structure of BIL having a hydrophilic carboxylic substituent. BIL has a longer duration of action due to its potent binding affinity to the H1 receptor. This review summarizes the properties, characteristics, chemistry along with analytical and bioanalytical methods used for estimation of BIL from different scientific articles. The literature has demonstrated some methods for quantification of BIL in various sample matrix and pharmaceutical products. Frequently and extensively used antihistaminics are in the clinic practice, a novel, effective, economic and safe analytical methodology is required for routine quality control analysis, bioavailability, and bioequivalence studies. Furthermore, this narrative review summarizes available data on chemistry, pharmacology and analysis of BIL in a different matrix.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Mini reviews in medicinal chemistry - 21(2021), 20 vom: 30., Seite 3183-3190

Sprache:

Englisch

Beteiligte Personen:

Sharma, Sanjay [VerfasserIn]
Hatware, Ketan [VerfasserIn]
Bhadane, Prashant [VerfasserIn]
Patil, Kiran [VerfasserIn]

Links:

Volltext

Themen:

Antihistamine
Antihistaminics
Benzimidazoles
Bilastine
Chemistry
Histamine H1 Antagonists
Journal Article
PA1123N395
Pharmacodynamics.
Pharmacokinetics
Piperidines
Review

Anmerkungen:

Date Completed 06.04.2022

Date Revised 06.04.2022

published: Print

Citation Status MEDLINE

doi:

10.2174/1389557521666210520171457

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM325433658